Rachael Blackman, MD, PhD

University of Minnesota Medical School


Graduate: PhD, Neuroscience, University of Minnesota, Minneapolis, MN, 2013
Undergraduate: BS, Neuroscience, Lafayette College, Easton, PA, 2004

I completed the Medical Scientist Training Program (MD/PhD) at the University of Minnesota, earning my PhD in Neuroscience in 2013 and MD in 2015. My PhD research focused on investigating the cellular basis for cognitive dysfunction in schizophrenia using an N-methyl-D-aspartate receptor (NMDAR) antagonist pharmacological model for the disease in non-human primates. From this work, I have published three first-authored papers to date.

During residency at Brown University, I have shifted from doing animal work to human work under the mentorship of Drs. David Badre and Noah Philip. I continue to study cognitive dysfunction in schizophrenia and now I am learning to conduct fMRI research. I won a pilot grant from the Center for Neurorestoration and Neurotechnology at the Providence VA Medical Center in order to conduct my study. The Research Training Program has provided me with tremendous support and time to enable me to pursue my research and expand my research into human studies. 


Zick, Blackman, Crowe, Amirikian, DeNicola, Netoff, Chafee. (2018). Blocking NMDAR disrupts spike timing and decouples monkey prefrontal circuits: Implications for activity-dependent disconnection in schizophrenia. Neuron, 98(6), 1243-1255.